Semaglutide

Semaglutide is a GLP-1 receptor agonist peptide analog commonly used in metabolic and endocrine research to study glucose regulation, appetite signaling, body-weight biology, and cardiometabolic outcomes.

• What it is: Long-acting GLP-1 receptor agonist.

• Common research use: Investigation of glycemic control pathways, insulin/glucagon dynamics, gastric-emptying effects, and appetite/energy-intake signaling.

• Typical study areas: Type 2 diabetes, obesity/weight-management biology, and cardiometabolic risk endpoints (including MACE-related outcomes in indicated populations).

For research use only. Not for human or veterinary use. Not for therapeutic or diagnostic use.